NEW YORK, Jan. 27, 2015 /PRNewswire/ -- CapRock Research analyst report issued by Small Cap IR. Obesity and diabetes have reached epidemic levels worldwide. The World Health Organization ("WHO") has estimated that in 2005, 217 million people worldwide had diabetes. By 2030, the WHO has predicted that this number will increase to at least 366 million people. In the United States, a 1999-2000 National Health and Nutrition Examination study concluded that 64.5% of U.S. adults were either overweight or obese, having a Body Mass Index (BMI) of 25 or more. Many believe that one of the causes of this epidemic is the amount of sugar that is consumed, leading food and beverage manufacturers to seek out alternatives to sugar. In 2011, according to market researcher Mintel, the market for the sugar substitutes had reached $6 billion. One of the fastest growing alternatives to sugar is stevia, a natural sweetener that is derived from a plant native to Central and South America.
Stevia First Corporation (OTCQB: STVF) is a development stage agricultural biotechnology company, headquartered in California's Central Valley, that is primarily engaged in developing novel, proprietary methods and fermentation technologies for the industrial production of stevia, an alternative sweetener. The company is intent on further developing these production methods in order to commercialize them at an industrial scale in order to sell stevia extract directly to multinational food, beverage, and ingredient companies.
An analyst report on STVF that includes a company overview, market and competition breakdown, recent events, outlook, analyst summary, valuation, and recommendation can be viewed by using the following link at no cost:
Copy and paste to browser may be required.
About Small Cap IR
We make the connection between sophisticated investors and high quality small cap companies. An issuer of reports written by chartered financial analysts (CFA's) who provide a straightforward assessment of the profiled company and have pledged to remain free of influence when writing research reports. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.
For more information and services provided beyond this release please use contact information provided below.
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
Content is researched, written and reviewed on a best-effort basis by a 3rd party research analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. We do not engage in high frequency trading.
A full disclaimer can be found by viewing the analyst report.
If you wish to have a company covered in more detail by our team, or wish to learn more about our services, please contact us at firstname.lastname@example.org. For any urgent concerns or inquiries please contact us at email@example.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Small Cap IR